In response to the COVID-19 pandemic, a large-scale randomized clinical trial is to initiate in the UK to assess some of the potential treatments for COVID-19. The RECOVERY trial, which is being sponsored by the University of Oxford and will be conducted at over 130 NHS hospitals, is the largest study of its kind in the world with over 5,000 planned participants. It has already recruited over 1,000 patients within just 15 days. Large studies like this will help provide data-driven evidence of which potential treatments are providing benefits to COVID-19 patients, says GlobalData, a leading data and analytics company.
Johanna Swanson, Product Manager at GlobalData comments:
“With more patients being enrolled and treatments being examined, we will get a better view of what is working for the differing levels of illness severity. The rapidity at which these studies are being launched provides some hope for faster results. We expect some safety and effectiveness data within the coming months.” ...
Read the full text on the site GMPnews.Net